These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1758554)

  • 1. Thrombolysis of blocked hemodialysis catheter using recombinant tissue-type plasminogen activator.
    Hannah A; Buttimore AL
    Nephron; 1991; 59(3):517-8. PubMed ID: 1758554
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
    Eyrich H; Walton T; Macon EJ; Howe A
    Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
    Pollo V; Dionízio D; Bucuvic EM; Castro JH; Ponce D
    Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients.
    Vlassopoulos D; Logothetis E; Arvanitis D; Noussias C; Magana P; Katopodis K; Hadjiconstantinou V
    Clin Nephrol; 1996 Jul; 46(1):77-8. PubMed ID: 8832159
    [No Abstract]   [Full Text] [Related]  

  • 5. Lytic therapy in central venous catheters for hemodialysis.
    McFarland HF; Dinwiddie L; Ferrell J; Forloines-Lynn S
    Nephrol Nurs J; 2002 Aug; 29(4):355-60; quiz 361-2. PubMed ID: 12224368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
    Jacobs BR; Haygood M; Hingl J
    J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of Long Versus Short Thrombolysis Times for Acutely Thrombosed Hemodialysis Native Fistulas.
    Regus S; Lang W; Heinz M; Uder M; Schmid A
    Vasc Endovascular Surg; 2017 Jul; 51(5):233-239. PubMed ID: 28639916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis catheter: induced giant right atrial thrombus.
    Aydogdu S; Celebi OO; Sahin D
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):363-4. PubMed ID: 20305544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of tissue plasminogen activator for reopening of clotted dialysis catheters.
    Paulsen D; Reisoether A; Aasen M; Fauchald P
    Nephron; 1993; 64(3):468-70. PubMed ID: 8341396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.
    Rodenhuis S; van't Hek LG; Vlasveld LT; Kröger R; Dubbelman R; van Tol RG
    Thorax; 1993 May; 48(5):558-9. PubMed ID: 8322245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant.
    Torres-Valdivieso MJ; Cobas J; Barrio C; Muñoz C; Pascual M; Orbea C; Rodriguez E; Gutiérrez F
    Am J Perinatol; 2003 Feb; 20(2):91-6. PubMed ID: 12660914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.
    Atkinson JB; Bagnall HA; Gomperts E
    JPEN J Parenter Enteral Nutr; 1990; 14(3):310-1. PubMed ID: 2112648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombosis of intrathoracic veins. A complication of venous catheterization for temporary hemodialysis].
    de Santos P; Valero R; Castillo J; Monsalve C; Balust J; Nalda MA
    Rev Esp Anestesiol Reanim; 1992; 39(5):319-21. PubMed ID: 1410756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to central venous catheter thrombosis in a patient with cystic fibrosis.
    Hull JH; Tucker W; Hatrick AG; Knight RK; Ho TB
    J Cyst Fibros; 2007 Nov; 6(6):417-8. PubMed ID: 17379581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteplase versus urokinase for occluded hemodialysis catheters.
    Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
    Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis.
    Nguyen TV; Dikun M
    Am J Health Syst Pharm; 2004 Sep; 61(18):1922-4. PubMed ID: 15487882
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of cryopreserved recombinant alteplase for declotting thrombosed central catheters.
    Isaac BF
    Ann Pharmacother; 2000 Apr; 34(4):533-4. PubMed ID: 10772443
    [No Abstract]   [Full Text] [Related]  

  • 19. Tackling the Achilles' heel of hemodialysis.
    Winkelmayer WC
    N Engl J Med; 2011 Jan; 364(4):372-4. PubMed ID: 21268730
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
    Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
    Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.